Watch an excerpt from RHU Provost and Professor of Microbiology Dr. Mahmoud Halablab’s interview on LBCI yesterday, where he discussed the promising use of mRNA technology, originally applied in developing the COVID-19 vaccine, in cancer treatment.
He described how this technology can be engineered to produce specific proteins for four cytokine hormones, opening new possibilities for targeted, innovative cancer treatments.
Watch the excerpt here.